This announcement is a separate document:
哈三联：上海荣正企业咨询服务（集团）股份有限公司关于哈尔滨三联药业股份有限公司2022年限制性股票激励计划第二个解除限售期解除限售条件成就及回购注销部分限制性股票相关事项之独立财务顾问报告
Kazakh Sanlian: Independent Financial Advisory Report of Shanghai Rongzheng Enterprise Consulting Service (Group) Co., Ltd. on matters relating to the achievements of the 2022 Restricted Stock Incentive Plan of Harbin Sanlian Pharmaceutical Co., Ltd., the results of lifting sales restrictions and the repurchase and cancellation of some restricted stocks
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.